At-Home Breast Cancer Treatment Approved

By the Editors

The FDA has approved Phesgo, a fixed-dose combination of pertuzumab plus trastuzumab with hyaluronidase, for subcutaneous injection in certain patients with HER2-positive breast cancer. The treatment can be administered at the patient's home by a clinician or in an outpatient treatment center.